The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS) (CoreValveIndia)
Sponsor: Medtronic
Terminated
This trial was terminated. No reason was provided.
Listed as NCT02759237, this observational or N/A phase trial focuses on Symptomatic Aortic Stenosis and remains terminated or withdrawn. Sponsored by Medtronic, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 3 earlier versions
-
Jul 2017 — Apr 2018 [monthly]
Terminated NA
-
Apr 2017 — Jul 2017 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2017 — Apr 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic
- Medtronic Cardiovascular
For direct contact, visit the study record on ClinicalTrials.gov .